Home
Company
Therapeutic focus
Parkinson's disease
Rett syndrome
Publications
Pipeline
NLX-112
NLX-101
Team
Management
Adrian Newman-Tancredi
Steven A. Johnson
Ronan Depoortere
Mark S. Kleven
Mark A. Varney
Fabienne Herbrecht
Violette Richin
Advisory Board
Francesc Artigas
Mark H.N. Corrigan
Daniel Hoyer
Christopher Jankosky
News
Contact
Search
Team
Ronan Depoortère, PhD
Director, Pharmacology
Read more: Ronan Depoortere
Steven A. Johnson, PhD
Vice-President, Drug Development
Read more: Steven A. Johnson
Mark S. Kleven, PhD
Senior VP Scientific Operations, COO
Read more: Mark S. Kleven
Fabienne Herbrecht, PhD
Director, Clinical Development
Read more: Fabienne Herbrecht
Mark A. Varney, Ph.D.
Co-Founder, Director
Read more: Mark A. Varney
Adrian Newman-Tancredi
Violette Richin
Home
Contact
Legal
Admin
Newsletter
Name
Email
Please enable the javascript to submit this form
Follow Neurolixis on:
Feeds Entries